1. Home
  2. MLCO vs WVE Comparison

MLCO vs WVE Comparison

Compare MLCO & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$5.65

Market Cap

2.5B

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.11

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLCO
WVE
Founded
2003
2012
Country
Hong Kong
Singapore
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
MLCO
WVE
Price
$5.65
$7.11
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
$10.10
$30.25
AVG Volume (30 Days)
1.2M
6.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$5.44
N/A
Revenue Next Year
$4.26
$85.67
P/E Ratio
$12.16
N/A
Revenue Growth
N/A
149.43
52 Week Low
$4.69
$5.02
52 Week High
$10.15
$21.73

Technical Indicators

Market Signals
Indicator
MLCO
WVE
Relative Strength Index (RSI) 48.18 30.03
Support Level $5.31 $6.66
Resistance Level $5.78 $8.08
Average True Range (ATR) 0.16 0.58
MACD 0.03 -0.02
Stochastic Oscillator 52.58 27.19

Price Performance

Historical Comparison
MLCO
WVE

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 81% from Macao, with the rest largely from the Philippines as of 2024.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: